![Ming Chang Ou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ming Chang Ou
Chief Executive Officer at VECTORITE BIOMEDICAL INC.
Network origin in Ming Chang Ou first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Other Transportation | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ming Chang Ou via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Tamkang | College/University | Undergraduate Degree | |
Ming Chi University of Technology | College/University | Undergraduate Degree | |
University of British Columbia | College/University | Doctorate Degree | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Graduate Degree | |
National Taiwan University | College/University | Graduate Degree | |
Soochow University /Taiwan/ | College/University | Undergraduate Degree | |
UWELL Biopharma, Inc.
![]() UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital. | Pharmaceuticals: Major | Chairman |
Statistics
International
Taiwan | 6 |
Canada | 2 |
United States | 2 |
Sectoral
Consumer Services | 7 |
Health Technology | 2 |
Operational
Director/Board Member | 7 |
Independent Dir/Board Member | 4 |
Undergraduate Degree | 3 |
Chairman | 2 |
Graduate Degree | 2 |
Most connected contacts
Insiders | |
---|---|
Hui Ching Yu | 3 |
Shih Hsing Tsai | 2 |
So Chu Chang | 2 |
Tsun Shan Chou | 2 |
Pai Jung Lai | 2 |
Chang En Tsai | 2 |
Tsung Hsien Yang | 1 |
Hsiang Yueh Meng | 1 |
Chien Ming Tang | 1 |
Kun Qi Jiang | 1 |
Bi Ru Huang | 1 |
- Stock Market
- Insiders
- Ming Chang Ou
- Company connections